Noxirut-P Tablet

Lornoxicam 8 mg + Paracetamol 325 mg Tablets

Noxirut-P Tablet — Lornoxicam 8 mg + Paracetamol 325 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Lornoxicam 8 mg + Paracetamol 325 mg
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 1010
Therapy G.P. / Surgery / Orthopaedics — NSAID + Analgesic
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Noxirut-P Tablet

Noxirut-P Tablet combines Lornoxicam 8 mg with Paracetamol 325 mg — synergistic peripheral COX inhibition (Lornoxicam) and central analgesic action (Paracetamol). Effective for moderate-to-severe acute pain with both inflammatory and non-inflammatory components.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Moderate-to-severe acute pain
  • Post-operative pain
  • Acute musculoskeletal pain
  • Dental pain
  • Headache (severe)

Mechanism of Action

Lornoxicam is a potent oxicam-class NSAID — non-selective COX-1/COX-2 inhibitor with strong analgesic and anti-inflammatory action. Shorter half-life (~4 hours) than other oxicams allowing dose flexibility. Comparable efficacy to opioid analgesics for post-operative pain. Paracetamol provides central analgesic and antipyretic action via COX-3 inhibition and endocannabinoid modulation.

Dosage & Administration

Adults: 1 tablet twice daily.

Side Effects

GI upset, peptic ulcer, fluid retention, hepatic and renal effects. Higher GI toxicity than COX-2 selective. Hepatotoxicity at high paracetamol doses.

Contraindications & Precautions

Active peptic ulcer, severe heart failure, third trimester pregnancy, severe renal/hepatic impairment, aspirin-sensitive asthma.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Noxirut-P Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Noxirut-P Tablet used for?

Noxirut-P Tablet contains Lornoxicam 8 mg + Paracetamol 325 mg. Used as per the indications described above.

How should Noxirut-P Tablet be taken?

As directed by your physician. Complete the prescribed course.

Is Noxirut-P Tablet available for PCD pharma franchise?

Yes, Trumac Healthcare offers Noxirut-P Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Noxirut-P Tablet be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Noxirut-P Tablet WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.